The United States on Feb. 22 crossed the staggering milestone of 500,000 Covid-19 deaths just over a year since the coronavirus pandemic claimed its first known victim in Santa Clara County, California.

Global deaths from Covid-19 are expected to top 100,000 per week “very soon,” the World Health Organization’s top emergency expert Mike Ryan said.

President-elect Joe Biden’s plan to boost the Covid-19 vaccine rollout – including by spending $20 billion to create mass vaccination centers – should help speed up putting shots into the arms of millions of Americans, experts and officials told Reuters.

The World Health Organization tightened guidelines on wearing face masks, recommending that, where Covid-19 is spreading, they be worn by everyone in health care facilities and for all interactions in poorly ventilated indoor spaces.

The United States recorded the country’s 12th million Covid-19 case, even as millions of Americans were expected to travel for the upcoming Thanksgiving holiday, ignoring warnings from health officials about furthering the spread of the infectious disease.

The U.S. death toll from Covid-19 surpassed a grim new milestone of 250,000 lives lost as New York City’s public school system – the nation’s largest – called a halt to in-classroom instruction, citing a jump in coronavirus infection rates.

Canada’s Medicago announced the successful production of a Virus-Like Particle (VLP) of the coronavirus just 20 days after obtaining the SARS-CoV-2 gene. The company is focused on developing a vaccine for COVID-19, the virus caused by SARS-CoV-2.

Could an arthritis medication show promise as a treatment for the symptoms related to the coronavirus? That’s what Regeneron and Sanofi intend to find out.

Biogen instructed company staff to work from home following additional employees testing positive for the coronavirus. According to reports, 15 employees who attended a management meeting in Boston tested positive for the virus.

A global coalition set up to fight epidemic diseases issued a call for $2 billion to support the development of a vaccine against the new coronavirus that is causing COVID-19 infections around the world.